Aurora Cannabis (TSE:ACB) Shares Up 9.9% – Time to Buy?

Aurora Cannabis Inc. (TSE:ACB)’s stock price was up 9.9% during mid-day trading on Thursday . The company traded as high as C$6.92 and last traded at C$6.88. Approximately 267,087 shares traded hands during trading, a decline of 54% from the average daily volume of 574,670 shares. The stock had previously closed at C$6.26.

Analyst Ratings Changes

ACB has been the subject of several recent analyst reports. ATB Capital dropped their price target on Aurora Cannabis from C$11.00 to C$8.50 in a research note on Tuesday, December 17th. Atb Cap Markets upgraded Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 5th. Finally, TD Securities upgraded Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th.

Aurora Cannabis Stock Down 2.1 %

The company has a current ratio of 3.42, a quick ratio of 2.48 and a debt-to-equity ratio of 18.72. The stock has a market capitalization of C$349.59 million, a P/E ratio of -7.89 and a beta of 2.71. The business has a 50-day moving average price of C$6.88 and a 200 day moving average price of C$6.96.

Insider Activity at Aurora Cannabis

In other Aurora Cannabis news, Senior Officer Andre Jerome sold 13,390 shares of the stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of C$9.30, for a total value of C$124,524.32.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.